Report
Brett Horn
EUR 850.00 For Business Accounts Only

Morningstar | Marsh & McLennan Is Making a Big Bet With JLT

We view Marsh & McLennan as something of a tollbooth business. Its leading position in the brokerage industry would be difficult to displace, and its sticky customer relationships allow it to benefit from a relatively stable level of insurance transactions, although it does have some exposure to the insurance pricing cycle. We think Marsh & McLennan’s future will largely resemble its past, with moderate growth and attractive profitability.In 2018, Marsh & McLennan saw a modest headwind turn into a modest tailwind. Because Marsh & McLennan generally takes a percentage of premium amounts as commission, it is exposed to the direction of the insurance pricing cycle. Reinsurance pricing had been very weak in recent years, and primary pricing had started to follow suit. However, the outsize level of catastrophe losses in the back half of 2017 provided a prompt to industry pricing. Prices moved up modestly, but the increases were lower than the industry has seen in the past after large catastrophe losses. In our view, the industry remains well-capitalized and competitive, which could put a bit of a lid on price increases. But with another flurry of catastrophe losses in 2018, this tailwind could persist into 2019.In September, Marsh & McLennan announced it will acquire Jardine Lloyd Thompson Group plc, in a deal valued at $5.6 billion. Historically, the company has been content with small bolt-on acquisitions, and it has been over a decade since the company completed a multi-billion-dollar deal. However, we think the deal makes strategic sense and the valuation looks reasonable, assuming Marsh & McLennan can achieve the expected cost synergies. Jardine’s brokerage business increases Marsh & McLennan’s specialty exposure as well as bulking out its presence in the U.K., Australia, and emerging markets. Management pointed to accelerating growth as a key consideration behind the deal. We like that Marsh & McLennan is focused on expanding its brokerage operations, which we view as the heart of its narrow moat, and the company doesn’t look to be expanding outside of its circle of competence to achieve this growth.
Underlying
Marsh & McLennan Companies Inc.

Marsh & McLennan Companies is a holding company. Through its subsidiaries, the company provides clients advice and solutions in risk, strategy and people. The company provides analysis, advice and transactional capabilities to clients. The company conducts business through two segments: Risk and Insurance Services, which includes risk management activities (risk advice, risk transfer and risk control and mitigation solutions) as well as insurance and reinsurance broking and services; and Consulting, which includes health, wealth and career services and products, and other management, economic and brand consulting services.

Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
Brett Horn

Other Reports on these Companies
Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch